Pherecydes Pharma Organizes a Scientific Symposium During the 23rd National Days of Infectiology
Phage therapy in 2022: French experience Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE, PEA-PME eligible), a biotech company specializing in precision phage therapy to treat resistant
Source: finanznachrichten.de